Miami Debates in Hematologic Malignancies (MDHM 2022)

Miami Debates in Hematologic Malignancies (MDHM 2022) is a conference dedicated to up-to-date review of the latest news in the field of hematologic malignancies.

Topics

• Bispecific and conjugated monoclonal antibodies
• Optimal treatments for newly diagnosed and relapsed patients
• Minimal residual disease (MRD) testing in the clinic
• Chemotherapy-free treatments
• Future role of bone marrow transplant
• CAR T cell and CAR NK cell therapies
• New drugs in development

Who should Attend

• Healthcare clinicians
• Hematologists
• Medical
• Hematologic oncologists
• Physicians
• Radiation and surgical oncologists
• Nurse practitioners
• Oncology nurses
• Researchers
• Occupational therapists
• Pharmacists and industry professionals working in the fields of oncology and hematology.